ANDA 64108, held by Ingenus Pharms LLC. Clindamycin Phosphate.
As of Nov 15, 2026, ANDA 64108 (Clindamycin Phosphate), held by Ingenus Pharms LLC, was first approved by FDA on Sep 27, 1996, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 27, 1996 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clindamycin PhosphateEQ 1% BASE ยท solution;topical | Clindamycin Phosphate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
